Thursday - March 26, 2026
Paul Hastings Secures Victory for Kyverna Therapeutics in the Northern District of California
March 25, 2026
LOS ANGELES, California, March 25 [Category: BizLaw/Legal] -- Paul Hastings, a law firm, issued the following news:

* * *

Paul Hastings Secures Victory for Kyverna Therapeutics in the Northern District of California

*

Paul Hastings LLP secured a victory for Kyverna Therapeutics (Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies to treat patients with autoimmune diseases, in the Northern District of C . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products